ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Allylamines Antifungal Drugs Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-27G18893
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Allylamines Antifungal Drugs Market Research Report 2025
BUY CHAPTERS

Global Allylamines Antifungal Drugs Market Research Report 2025

Code: QYRE-Auto-27G18893
Report
April 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Gilead Sciences
Abbott Laboratories
Bayer
Sandoz Inc
Mylan NV
TEVA
Dr. Reddy’s Laboratories
Cipla Ltd
Qilu Pharmaceutical
Xiuzheng Pharmaceutical Group
Chongqing Huapont Pharmaceutical
Fuyuan Pharmaceutical
Hunan Dinuo Pharmaceutical
Nanjing Chenggong Pharmaceutical
Yangtze River Pharmaceutical Group
Tongyao Pharmaceutical Group
Shandong Chenxin Pharmaceutical
Aobang Pharmaceutical

Allylamines Antifungal Drugs Market Size

The global market for Allylamines Antifungal Drugs was valued at US$ 5470 million in the year 2024 and is projected to reach a revised size of US$ 7266 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Allylamines Antifungal Drugs Market

Allylamines Antifungal Drugs Market

Allylamines antifungal drugs are a class of drugs that exert antifungal effects by specifically inhibiting squalene epoxidase (SE) in the ergosterol synthesis pathway of fungal cell membranes. These drugs have allylamine groups in their chemical structures, which inhibit SE and block the conversion of squalene to 2,3-oxidized squalene, leading to squalene accumulation and ergosterol deficiency in fungal cells. This dual effect not only destroys the structural and functional integrity of fungal cell membranes, but also causes a large accumulation of squalene inside the cells, resulting in toxicity and ultimately leading to fungal cell death. These drugs have relatively low toxicity to human cells and good selectivity.
Due to the advantageous position in the treatment of superficial fungal infections, allylamines antifungal drugs have maintained a stable market share and growth potential in recent years. The main driving factors are the rising incidence rate of fungal infection, the improvement of patients' treatment awareness, product innovation and dosage form improvement, brand marketing and channel expansion. The representative drug terbinafine has become one of the gold standard drugs for treating superficial fungal infections, especially onychomycosis, worldwide. Naletifen and Butinifen are also important members of the allylamine family, mainly used for topical treatment. The market competition is fierce, with companies such as Pfizer, Novartis, Gilead Sciences competing in product quality, efficacy, price, and other aspects to compete for market share. Original drug brands usually have a high level of popularity, but their prices are also relatively high; However, domestic enterprises such as Qilu Pharmaceutical and Xiuzheng Pharmaceutical Group attract consumers with price advantages. With the continuous advancement of pharmaceutical research and development technology, more new types of allylamines antifungal drugs may emerge in the future, which may improve and optimize their efficacy, safety, and administration methods. Some studies and clinical trials have begun to explore the potential application of allylamines antifungal drugs in the treatment of deep fungal infections. If a breakthrough is made, it will further expand the market space. In addition, the application of this type of drugs in other fields such as cosmetic additives also needs further development. Governments around the world are continuously strengthening their regulatory efforts and strictly regulating the production, sales, and use of allylamines antifungal drugs. This will help improve the concentration and competitiveness of the entire market, and promote the healthy development of the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Allylamines Antifungal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allylamines Antifungal Drugs.
The Allylamines Antifungal Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allylamines Antifungal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allylamines Antifungal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Allylamines Antifungal Drugs Market Report

Report Metric Details
Report Name Allylamines Antifungal Drugs Market
Accounted market size in year US$ 5470 million
Forecasted market size in 2031 US$ 7266 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Naftifine
  • Terbinafine
  • Butenafine
  • Others
Segment by Application
  • Dermatophytosis
  • Tinea Versicolor
  • Tinea Capitis
  • Candidiasis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Gilead Sciences, Abbott Laboratories, Bayer, Sandoz, Mylan, Teva, Dr. Reddy's Laboratories, Cipla, Qilu Pharmaceutical, Xiuzheng Pharmaceutical Group, Chongqing Huapont Pharmaceutical, Fuyuan Pharmaceutical, Tongyao Pharmaceutical Group, Shandong Chenxin Pharmaceutical, Hunan Dinuo Pharmaceutical, Aobang Pharmaceutical, Nanjing Chenggong Pharmaceutical, Yangtze River Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Allylamines Antifungal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Allylamines Antifungal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Allylamines Antifungal Drugs Market growing?

Ans: The Allylamines Antifungal Drugs Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Allylamines Antifungal Drugs Market size in 2031?

Ans: The Allylamines Antifungal Drugs Market size in 2031 will be US$ 7266 million.

Who are the main players in the Allylamines Antifungal Drugs Market report?

Ans: The main players in the Allylamines Antifungal Drugs Market are Pfizer, Novartis, Gilead Sciences, Abbott Laboratories, Bayer, Sandoz, Mylan, Teva, Dr. Reddy's Laboratories, Cipla, Qilu Pharmaceutical, Xiuzheng Pharmaceutical Group, Chongqing Huapont Pharmaceutical, Fuyuan Pharmaceutical, Tongyao Pharmaceutical Group, Shandong Chenxin Pharmaceutical, Hunan Dinuo Pharmaceutical, Aobang Pharmaceutical, Nanjing Chenggong Pharmaceutical, Yangtze River Pharmaceutical Group

What are the Application segmentation covered in the Allylamines Antifungal Drugs Market report?

Ans: The Applications covered in the Allylamines Antifungal Drugs Market report are Dermatophytosis, Tinea Versicolor, Tinea Capitis, Candidiasis, Others

What are the Type segmentation covered in the Allylamines Antifungal Drugs Market report?

Ans: The Types covered in the Allylamines Antifungal Drugs Market report are Naftifine, Terbinafine, Butenafine, Others

1 Allylamines Antifungal Drugs Market Overview
1.1 Product Definition
1.2 Allylamines Antifungal Drugs by Type
1.2.1 Global Allylamines Antifungal Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Naftifine
1.2.3 Terbinafine
1.2.4 Butenafine
1.2.5 Others
1.3 Allylamines Antifungal Drugs by Application
1.3.1 Global Allylamines Antifungal Drugs Market Value by Application (2024 VS 2031)
1.3.2 Dermatophytosis
1.3.3 Tinea Versicolor
1.3.4 Tinea Capitis
1.3.5 Candidiasis
1.3.6 Others
1.4 Global Allylamines Antifungal Drugs Market Size Estimates and Forecasts
1.4.1 Global Allylamines Antifungal Drugs Revenue 2020-2031
1.4.2 Global Allylamines Antifungal Drugs Sales 2020-2031
1.4.3 Global Allylamines Antifungal Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Allylamines Antifungal Drugs Market Competition by Manufacturers
2.1 Global Allylamines Antifungal Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Allylamines Antifungal Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Allylamines Antifungal Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Allylamines Antifungal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Allylamines Antifungal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Allylamines Antifungal Drugs, Product Type & Application
2.7 Global Key Manufacturers of Allylamines Antifungal Drugs, Date of Enter into This Industry
2.8 Global Allylamines Antifungal Drugs Market Competitive Situation and Trends
2.8.1 Global Allylamines Antifungal Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Allylamines Antifungal Drugs Players Market Share by Revenue
2.8.3 Global Allylamines Antifungal Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Allylamines Antifungal Drugs Market Scenario by Region
3.1 Global Allylamines Antifungal Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Allylamines Antifungal Drugs Sales by Region: 2020-2031
3.2.1 Global Allylamines Antifungal Drugs Sales by Region: 2020-2025
3.2.2 Global Allylamines Antifungal Drugs Sales by Region: 2026-2031
3.3 Global Allylamines Antifungal Drugs Revenue by Region: 2020-2031
3.3.1 Global Allylamines Antifungal Drugs Revenue by Region: 2020-2025
3.3.2 Global Allylamines Antifungal Drugs Revenue by Region: 2026-2031
3.4 North America Allylamines Antifungal Drugs Market Facts & Figures by Country
3.4.1 North America Allylamines Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Allylamines Antifungal Drugs Sales by Country (2020-2031)
3.4.3 North America Allylamines Antifungal Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Allylamines Antifungal Drugs Market Facts & Figures by Country
3.5.1 Europe Allylamines Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Allylamines Antifungal Drugs Sales by Country (2020-2031)
3.5.3 Europe Allylamines Antifungal Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Allylamines Antifungal Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Allylamines Antifungal Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Allylamines Antifungal Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Allylamines Antifungal Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Allylamines Antifungal Drugs Market Facts & Figures by Country
3.7.1 Latin America Allylamines Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Allylamines Antifungal Drugs Sales by Country (2020-2031)
3.7.3 Latin America Allylamines Antifungal Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Allylamines Antifungal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Allylamines Antifungal Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Allylamines Antifungal Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Allylamines Antifungal Drugs Sales by Type (2020-2031)
4.1.1 Global Allylamines Antifungal Drugs Sales by Type (2020-2025)
4.1.2 Global Allylamines Antifungal Drugs Sales by Type (2026-2031)
4.1.3 Global Allylamines Antifungal Drugs Sales Market Share by Type (2020-2031)
4.2 Global Allylamines Antifungal Drugs Revenue by Type (2020-2031)
4.2.1 Global Allylamines Antifungal Drugs Revenue by Type (2020-2025)
4.2.2 Global Allylamines Antifungal Drugs Revenue by Type (2026-2031)
4.2.3 Global Allylamines Antifungal Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Allylamines Antifungal Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Allylamines Antifungal Drugs Sales by Application (2020-2031)
5.1.1 Global Allylamines Antifungal Drugs Sales by Application (2020-2025)
5.1.2 Global Allylamines Antifungal Drugs Sales by Application (2026-2031)
5.1.3 Global Allylamines Antifungal Drugs Sales Market Share by Application (2020-2031)
5.2 Global Allylamines Antifungal Drugs Revenue by Application (2020-2031)
5.2.1 Global Allylamines Antifungal Drugs Revenue by Application (2020-2025)
5.2.2 Global Allylamines Antifungal Drugs Revenue by Application (2026-2031)
5.2.3 Global Allylamines Antifungal Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Allylamines Antifungal Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Allylamines Antifungal Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Allylamines Antifungal Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Company Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gilead Sciences Allylamines Antifungal Drugs Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Company Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Laboratories Allylamines Antifungal Drugs Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Allylamines Antifungal Drugs Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Company Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sandoz Allylamines Antifungal Drugs Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Allylamines Antifungal Drugs Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Allylamines Antifungal Drugs Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Dr. Reddy's Laboratories
6.9.1 Dr. Reddy's Laboratories Company Information
6.9.2 Dr. Reddy's Laboratories Description and Business Overview
6.9.3 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product Portfolio
6.9.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Company Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cipla Allylamines Antifungal Drugs Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Qilu Pharmaceutical
6.11.1 Qilu Pharmaceutical Company Information
6.11.2 Qilu Pharmaceutical Description and Business Overview
6.11.3 Qilu Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Qilu Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.11.5 Qilu Pharmaceutical Recent Developments/Updates
6.12 Xiuzheng Pharmaceutical Group
6.12.1 Xiuzheng Pharmaceutical Group Company Information
6.12.2 Xiuzheng Pharmaceutical Group Description and Business Overview
6.12.3 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
6.12.5 Xiuzheng Pharmaceutical Group Recent Developments/Updates
6.13 Chongqing Huapont Pharmaceutical
6.13.1 Chongqing Huapont Pharmaceutical Company Information
6.13.2 Chongqing Huapont Pharmaceutical Description and Business Overview
6.13.3 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.13.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
6.14 Fuyuan Pharmaceutical
6.14.1 Fuyuan Pharmaceutical Company Information
6.14.2 Fuyuan Pharmaceutical Description and Business Overview
6.14.3 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.14.5 Fuyuan Pharmaceutical Recent Developments/Updates
6.15 Tongyao Pharmaceutical Group
6.15.1 Tongyao Pharmaceutical Group Company Information
6.15.2 Tongyao Pharmaceutical Group Description and Business Overview
6.15.3 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
6.15.5 Tongyao Pharmaceutical Group Recent Developments/Updates
6.16 Shandong Chenxin Pharmaceutical
6.16.1 Shandong Chenxin Pharmaceutical Company Information
6.16.2 Shandong Chenxin Pharmaceutical Description and Business Overview
6.16.3 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.16.5 Shandong Chenxin Pharmaceutical Recent Developments/Updates
6.17 Hunan Dinuo Pharmaceutical
6.17.1 Hunan Dinuo Pharmaceutical Company Information
6.17.2 Hunan Dinuo Pharmaceutical Description and Business Overview
6.17.3 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.17.5 Hunan Dinuo Pharmaceutical Recent Developments/Updates
6.18 Aobang Pharmaceutical
6.18.1 Aobang Pharmaceutical Company Information
6.18.2 Aobang Pharmaceutical Description and Business Overview
6.18.3 Aobang Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Aobang Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.18.5 Aobang Pharmaceutical Recent Developments/Updates
6.19 Nanjing Chenggong Pharmaceutical
6.19.1 Nanjing Chenggong Pharmaceutical Company Information
6.19.2 Nanjing Chenggong Pharmaceutical Description and Business Overview
6.19.3 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product Portfolio
6.19.5 Nanjing Chenggong Pharmaceutical Recent Developments/Updates
6.20 Yangtze River Pharmaceutical Group
6.20.1 Yangtze River Pharmaceutical Group Company Information
6.20.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.20.3 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product Portfolio
6.20.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Allylamines Antifungal Drugs Industry Chain Analysis
7.2 Allylamines Antifungal Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Allylamines Antifungal Drugs Production Mode & Process Analysis
7.4 Allylamines Antifungal Drugs Sales and Marketing
7.4.1 Allylamines Antifungal Drugs Sales Channels
7.4.2 Allylamines Antifungal Drugs Distributors
7.5 Allylamines Antifungal Drugs Customer Analysis
8 Allylamines Antifungal Drugs Market Dynamics
8.1 Allylamines Antifungal Drugs Industry Trends
8.2 Allylamines Antifungal Drugs Market Drivers
8.3 Allylamines Antifungal Drugs Market Challenges
8.4 Allylamines Antifungal Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Gilead Sciences
Abbott Laboratories
Bayer
Sandoz Inc
Mylan NV
TEVA
Dr. Reddy’s Laboratories
Cipla Ltd
Qilu Pharmaceutical
Xiuzheng Pharmaceutical Group
Chongqing Huapont Pharmaceutical
Fuyuan Pharmaceutical
Hunan Dinuo Pharmaceutical
Nanjing Chenggong Pharmaceutical
Yangtze River Pharmaceutical Group
Tongyao Pharmaceutical Group
Shandong Chenxin Pharmaceutical
Aobang Pharmaceutical
List of Tables
 Table 1. Global Allylamines Antifungal Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Allylamines Antifungal Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Allylamines Antifungal Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Allylamines Antifungal Drugs Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Allylamines Antifungal Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Allylamines Antifungal Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Allylamines Antifungal Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Allylamines Antifungal Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Allylamines Antifungal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Allylamines Antifungal Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Allylamines Antifungal Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Allylamines Antifungal Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Allylamines Antifungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allylamines Antifungal Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Allylamines Antifungal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Allylamines Antifungal Drugs Sales by Region (2020-2025) & (Units)
 Table 18. Global Allylamines Antifungal Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Allylamines Antifungal Drugs Sales by Region (2026-2031) & (Units)
 Table 20. Global Allylamines Antifungal Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Allylamines Antifungal Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Allylamines Antifungal Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Allylamines Antifungal Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Allylamines Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Allylamines Antifungal Drugs Sales by Country (2020-2025) & (Units)
 Table 27. North America Allylamines Antifungal Drugs Sales by Country (2026-2031) & (Units)
 Table 28. North America Allylamines Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Allylamines Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Allylamines Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Allylamines Antifungal Drugs Sales by Country (2020-2025) & (Units)
 Table 32. Europe Allylamines Antifungal Drugs Sales by Country (2026-2031) & (Units)
 Table 33. Europe Allylamines Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Allylamines Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Allylamines Antifungal Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Allylamines Antifungal Drugs Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Allylamines Antifungal Drugs Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Allylamines Antifungal Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Allylamines Antifungal Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Allylamines Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Allylamines Antifungal Drugs Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Allylamines Antifungal Drugs Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Allylamines Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Allylamines Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Allylamines Antifungal Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Allylamines Antifungal Drugs Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Allylamines Antifungal Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Allylamines Antifungal Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Allylamines Antifungal Drugs Sales (Units) by Type (2020-2025)
 Table 51. Global Allylamines Antifungal Drugs Sales (Units) by Type (2026-2031)
 Table 52. Global Allylamines Antifungal Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Allylamines Antifungal Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Allylamines Antifungal Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Allylamines Antifungal Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Allylamines Antifungal Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Allylamines Antifungal Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Allylamines Antifungal Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Allylamines Antifungal Drugs Sales (Units) by Application (2020-2025)
 Table 61. Global Allylamines Antifungal Drugs Sales (Units) by Application (2026-2031)
 Table 62. Global Allylamines Antifungal Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Allylamines Antifungal Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Allylamines Antifungal Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Allylamines Antifungal Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Allylamines Antifungal Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Allylamines Antifungal Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Allylamines Antifungal Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Allylamines Antifungal Drugs Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Allylamines Antifungal Drugs Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Gilead Sciences Company Information
 Table 81. Gilead Sciences Description and Business Overview
 Table 82. Gilead Sciences Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Gilead Sciences Allylamines Antifungal Drugs Product
 Table 84. Gilead Sciences Recent Developments/Updates
 Table 85. Abbott Laboratories Company Information
 Table 86. Abbott Laboratories Description and Business Overview
 Table 87. Abbott Laboratories Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Abbott Laboratories Allylamines Antifungal Drugs Product
 Table 89. Abbott Laboratories Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer Allylamines Antifungal Drugs Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Sandoz Company Information
 Table 96. Sandoz Description and Business Overview
 Table 97. Sandoz Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sandoz Allylamines Antifungal Drugs Product
 Table 99. Sandoz Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Allylamines Antifungal Drugs Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Teva Company Information
 Table 106. Teva Description and Business Overview
 Table 107. Teva Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Teva Allylamines Antifungal Drugs Product
 Table 109. Teva Recent Developments/Updates
 Table 110. Dr. Reddy's Laboratories Company Information
 Table 111. Dr. Reddy's Laboratories Description and Business Overview
 Table 112. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Dr. Reddy's Laboratories Allylamines Antifungal Drugs Product
 Table 114. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 115. Cipla Company Information
 Table 116. Cipla Description and Business Overview
 Table 117. Cipla Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Cipla Allylamines Antifungal Drugs Product
 Table 119. Cipla Recent Developments/Updates
 Table 120. Qilu Pharmaceutical Company Information
 Table 121. Qilu Pharmaceutical Description and Business Overview
 Table 122. Qilu Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Qilu Pharmaceutical Allylamines Antifungal Drugs Product
 Table 124. Qilu Pharmaceutical Recent Developments/Updates
 Table 125. Xiuzheng Pharmaceutical Group Company Information
 Table 126. Xiuzheng Pharmaceutical Group Description and Business Overview
 Table 127. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Xiuzheng Pharmaceutical Group Allylamines Antifungal Drugs Product
 Table 129. Xiuzheng Pharmaceutical Group Recent Developments/Updates
 Table 130. Chongqing Huapont Pharmaceutical Company Information
 Table 131. Chongqing Huapont Pharmaceutical Description and Business Overview
 Table 132. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Chongqing Huapont Pharmaceutical Allylamines Antifungal Drugs Product
 Table 134. Chongqing Huapont Pharmaceutical Recent Developments/Updates
 Table 135. Fuyuan Pharmaceutical Company Information
 Table 136. Fuyuan Pharmaceutical Description and Business Overview
 Table 137. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Fuyuan Pharmaceutical Allylamines Antifungal Drugs Product
 Table 139. Fuyuan Pharmaceutical Recent Developments/Updates
 Table 140. Tongyao Pharmaceutical Group Company Information
 Table 141. Tongyao Pharmaceutical Group Description and Business Overview
 Table 142. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Tongyao Pharmaceutical Group Allylamines Antifungal Drugs Product
 Table 144. Tongyao Pharmaceutical Group Recent Developments/Updates
 Table 145. Shandong Chenxin Pharmaceutical Company Information
 Table 146. Shandong Chenxin Pharmaceutical Description and Business Overview
 Table 147. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Shandong Chenxin Pharmaceutical Allylamines Antifungal Drugs Product
 Table 149. Shandong Chenxin Pharmaceutical Recent Developments/Updates
 Table 150. Hunan Dinuo Pharmaceutical Company Information
 Table 151. Hunan Dinuo Pharmaceutical Description and Business Overview
 Table 152. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Hunan Dinuo Pharmaceutical Allylamines Antifungal Drugs Product
 Table 154. Hunan Dinuo Pharmaceutical Recent Developments/Updates
 Table 155. Aobang Pharmaceutical Company Information
 Table 156. Aobang Pharmaceutical Description and Business Overview
 Table 157. Aobang Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Aobang Pharmaceutical Allylamines Antifungal Drugs Product
 Table 159. Aobang Pharmaceutical Recent Developments/Updates
 Table 160. Nanjing Chenggong Pharmaceutical Company Information
 Table 161. Nanjing Chenggong Pharmaceutical Description and Business Overview
 Table 162. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Nanjing Chenggong Pharmaceutical Allylamines Antifungal Drugs Product
 Table 164. Nanjing Chenggong Pharmaceutical Recent Developments/Updates
 Table 165. Yangtze River Pharmaceutical Group Company Information
 Table 166. Yangtze River Pharmaceutical Group Description and Business Overview
 Table 167. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Yangtze River Pharmaceutical Group Allylamines Antifungal Drugs Product
 Table 169. Yangtze River Pharmaceutical Group Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Allylamines Antifungal Drugs Distributors List
 Table 173. Allylamines Antifungal Drugs Customers List
 Table 174. Allylamines Antifungal Drugs Market Trends
 Table 175. Allylamines Antifungal Drugs Market Drivers
 Table 176. Allylamines Antifungal Drugs Market Challenges
 Table 177. Allylamines Antifungal Drugs Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Allylamines Antifungal Drugs
 Figure 2. Global Allylamines Antifungal Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Allylamines Antifungal Drugs Market Share by Type: 2024 & 2031
 Figure 4. Naftifine Product Picture
 Figure 5. Terbinafine Product Picture
 Figure 6. Butenafine Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Allylamines Antifungal Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Allylamines Antifungal Drugs Market Share by Application: 2024 & 2031
 Figure 10. Dermatophytosis
 Figure 11. Tinea Versicolor
 Figure 12. Tinea Capitis
 Figure 13. Candidiasis
 Figure 14. Others
 Figure 15. Global Allylamines Antifungal Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Allylamines Antifungal Drugs Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Allylamines Antifungal Drugs Sales (2020-2031) & (Units)
 Figure 18. Global Allylamines Antifungal Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 19. Allylamines Antifungal Drugs Report Years Considered
 Figure 20. Allylamines Antifungal Drugs Sales Share by Manufacturers in 2024
 Figure 21. Global Allylamines Antifungal Drugs Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Allylamines Antifungal Drugs Players: Market Share by Revenue in Allylamines Antifungal Drugs in 2024
 Figure 23. Allylamines Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Allylamines Antifungal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Allylamines Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 26. North America Allylamines Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. United States Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Allylamines Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 30. Europe Allylamines Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Allylamines Antifungal Drugs Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Allylamines Antifungal Drugs Revenue Market Share by Region (2020-2031)
 Figure 38. China Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Allylamines Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Allylamines Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Colombia Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Allylamines Antifungal Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Allylamines Antifungal Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Allylamines Antifungal Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Allylamines Antifungal Drugs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Allylamines Antifungal Drugs by Type (2020-2031)
 Figure 58. Global Allylamines Antifungal Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Allylamines Antifungal Drugs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Allylamines Antifungal Drugs by Application (2020-2031)
 Figure 61. Global Allylamines Antifungal Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 62. Allylamines Antifungal Drugs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Terbinafine Lamisil Market Research Report 2024
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
Global Fluconazole Preparation Market Research Report 2024
Global Azole Antifungals Market Research Report 2024
Global Echinocandins Antifungal Drugs Market Research Report 2024
Global Antifungal Drugs for Skin Market Research Report 2024
Global Anti fungal Drugs Market Insights Forecast to 2030
Global Medical Antifungal Agent Market Research Report 2025
Global Drugs for Vulvovaginal Candidiasis Market Research Report 2025
Global Anti Dermatomycosis Treatment Market Research Report 2025
Global Polyene Antifungal Drugs API Market Research Report 2024
Global Itraconazole Inhibitors Market Research Report 2024
Global N Allylamine Market Research Report 2024
Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Fungal Agents Market Insights Forecast to 2030
Global Clotrimazole Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Fungal Drugs for Treatment of Tinea Market Research Report 2025
Global Naftifine Hydrochloride Ointment Market Insights Forecast to 2030
Global Hydroxylamine Antioxidant Market Research Report 2024
Isavuconazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions